Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis

Non-invasive drug delivery across the blood–brain barrier (BBB) represents a significant advancement in treating neurological diseases. The BBB is a tightly packed layer of endothelial cells that shields the brain from harmful substances in the blood, allowing necessary nutrients to pass through. It...

Full description

Bibliographic Details
Main Author: Sarfaraz K. Niazi
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/11/2599
_version_ 1827638951897202688
author Sarfaraz K. Niazi
author_facet Sarfaraz K. Niazi
author_sort Sarfaraz K. Niazi
collection DOAJ
description Non-invasive drug delivery across the blood–brain barrier (BBB) represents a significant advancement in treating neurological diseases. The BBB is a tightly packed layer of endothelial cells that shields the brain from harmful substances in the blood, allowing necessary nutrients to pass through. It is a highly selective barrier, which poses a challenge to delivering therapeutic agents into the brain. Several non-invasive procedures and devices have been developed or are currently being investigated to enhance drug delivery across the BBB. This paper presents a review and a prospective analysis of the art and science that address pharmacology, technology, delivery systems, regulatory approval, ethical concerns, and future possibilities.
first_indexed 2024-03-09T16:30:59Z
format Article
id doaj.art-016f363e31a44f00bc2fd222cb230690
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T16:30:59Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-016f363e31a44f00bc2fd222cb2306902023-11-24T15:01:04ZengMDPI AGPharmaceutics1999-49232023-11-011511259910.3390/pharmaceutics15112599Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective AnalysisSarfaraz K. Niazi0College of Pharmacy, University of Illinois, Chicago, IL 60612, USANon-invasive drug delivery across the blood–brain barrier (BBB) represents a significant advancement in treating neurological diseases. The BBB is a tightly packed layer of endothelial cells that shields the brain from harmful substances in the blood, allowing necessary nutrients to pass through. It is a highly selective barrier, which poses a challenge to delivering therapeutic agents into the brain. Several non-invasive procedures and devices have been developed or are currently being investigated to enhance drug delivery across the BBB. This paper presents a review and a prospective analysis of the art and science that address pharmacology, technology, delivery systems, regulatory approval, ethical concerns, and future possibilities.https://www.mdpi.com/1999-4923/15/11/2599neurodegenerative disordersblood–brain barriernon-invasive deliverydevice-related deliveryAlzheimer’s diseaseParkinson’s disease
spellingShingle Sarfaraz K. Niazi
Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis
Pharmaceutics
neurodegenerative disorders
blood–brain barrier
non-invasive delivery
device-related delivery
Alzheimer’s disease
Parkinson’s disease
title Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis
title_full Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis
title_fullStr Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis
title_full_unstemmed Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis
title_short Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis
title_sort non invasive drug delivery across the blood brain barrier a prospective analysis
topic neurodegenerative disorders
blood–brain barrier
non-invasive delivery
device-related delivery
Alzheimer’s disease
Parkinson’s disease
url https://www.mdpi.com/1999-4923/15/11/2599
work_keys_str_mv AT sarfarazkniazi noninvasivedrugdeliveryacrossthebloodbrainbarrieraprospectiveanalysis